Top

Published in:

01-06-2009 | Editorial

Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa

Authors: Angela Kaida, David R. Bangsberg, Glenda Gray, Robert S. Hogg, Rachel King, Cari L. Miller

Published in: AIDS and Behavior | Special Issue 1/2009

Excerpt

Recent years have witnessed an unprecedented global effort aimed at providing universal access to highly active antiretroviral therapy (HAART), however, comparatively little attention has been given to how HAART may affect reproductive decision-making, sexual and reproductive practices, and fertility.¹ These issues are particularly critical in HIV endemic settings where the majority of new infections occur among women (UNAIDS 2008). …

Please note that the term fertility is being used in the demographic sense, as in the actual level of reproduction based on the number of live births that occur, rather than the biologic capability to reproduce (termed fecundity).

Forrest, J., & Kaida, A. (2008). Conference summary report: Switching gears in HIV research: Building an international research agenda on the impact of HAART on fertility in sub-Saharan Africa. Soweto and Johannesburg, South Africa, Perinatal HIV Research Unit (PHRU). Available at: http://www.phru.co.za/pdf/conference/joburg_conference_summary_report_may30_2008.pdf. Accessed 1 April 2009.

Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. (2008). World population prospects: The 2008 revision. United Nations Secretariat.

UNAIDS. (2008). Report on the global HIV/AIDS epidemic 2008. Geneva: UNAIDS.

Title: Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa
Authors: Angela Kaida
David R. Bangsberg
Glenda Gray
Robert S. Hogg
Rachel King
Cari L. Miller
Publication date: 01-06-2009
Publisher: Springer US
Published in: AIDS and Behavior / Issue Special Issue 1/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-009-9568-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2009

A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions among HIV-Positive Women in Soweto, South Africa

Fertility Intentions and Reproductive Health Care Needs of People Living with HIV in Cape Town, South Africa: Implications for Integrating Reproductive Health and HIV Care Services

Male Involvement in PMTCT Services in Mbeya Region, Tanzania

Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time

Perceptions of HIV and Fertility Among Adolescents in Soweto, South Africa: Stigma and Social Barriers Continue to Hinder Progress

Women Living with HIV in South Africa and Their Concerns About Fertility

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials